- Datum04.04.2025
- Uhrzeit17:00 - 18:00 Uhr
- Veranstalter
XTB
Jens Klatt
Moderator
Aerpio Pharmaceuticals Inc. Aktie
Verkaufen
Kaufen
Aerpio Pharmaceuticals Inc. Chart
Aerpio Pharmaceuticals Inc. Realtime-Kurs
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Baader | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
-2,38 %
Intraday
0,00 %
1 Woche
-11,06 %
1 Monat
-35,02 %
Seit Jahresbeginn
-5,53 %
1 Jahr
-88,56 %
3 Jahre
-74,21 %
5 Jahre
Wikifolio
Passender Service zu Aerpio Pharmaceuticals Inc.
Webinar zu Aerpio Pharmaceuticals Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)1,210-3,812
- Jahrestief / Hoch ($)1,850-3,812
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Aerpio Pharmaceuticals Inc.
Keine Dividenden verfügbar
Termine von Aerpio Pharmaceuticals Inc.
Keine aktuellen Termine
Beschreibung
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.
